BACKGROUND
Cerebral radionecrosis is a possible complication of brain radiation therap
y in patients with primary or metastatic tumors. This retrospective study e
valuated the role of Tc-99m hexamethyl propyleneamine oxime (HMPAO) scintig
raphy in monitoring the effects of radiation on the brain.
METHODS
Ninety-eight patients (41 female, 57 male) with a mean age of 51 years (ran
ge, 16-82 years) underwent 128 sets of single photon emission computed tomo
graphy studies. TI-201 and Tc-99m HMPAO single-photon emission computed tom
ography studies were performed for tumor localization and evaluation of the
effect of radiation on the cerebral cortex. Thirty concomitant neuropsycho
logical tests and 96 anatomic imaging (computed tomography/magnetic resonan
ce imaging) were performed. The average radiation dose was 52 Gy delivered
as 1.8 to 2 Gy/fraction. Thirty-two patients received an average dose of 16
0 mCi of I-125 EGFr concomitantly, The average follow-up period was 34 mont
hs. Abnormalities away from the tumor site were interpreted as positive on
HMPAO studies, neuropsychological testing, or anatomic imaging; otherwise,
they were classified as negative.
RESULTS
There were 10/45 (22%) and 75/83 (90%) abnormal HMPAO study results before
and after radiation therapy. The HMPAO studies compared with neuropsycholog
ical testing showed 3/13 (23%) and 14/17 (82%) concordant abnormalities in
addition to tumor site in patients pre Versus postradiation therapy. There
was better concordance of HMPAO and anatomic imaging in 22/30 (76%) patient
s versus 24/67 (36%) patients before radiation therapy. HMPAO imaging after
radiation therapy revealed significantly more perfusion abnormalities. The
re were significant differences between ail of the aforementioned parameter
s.
CONCLUSION
Tc-99m HMPAO imaging is useful in the evaluation of the effects of radiatio
n therapy on the brain and is highly concordant with neuropsychological tes
ting. It is superior to anatomic studies in identifying radiation-induced c
hanges.